Southampton, United Kingdom

Ali Roghanian

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ali Roghanian

Introduction

Ali Roghanian is a prominent inventor based in Southampton, GB. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of four patents to his name, Roghanian's work focuses on the development of antibody-based therapies aimed at improving patient outcomes in cancer treatment.

Latest Patents

Roghanian's latest patents include groundbreaking work on the combination and use of antibodies. One notable patent describes a first antibody molecule that specifically binds to FcγRIIb via its Fab region, while lacking the Fc region or having reduced binding to Fcγ receptors. This antibody is designed to be used in combination with a second antibody molecule that binds to a receptor present on an immune cell, which suppresses anti-cancer immunity. The second antibody molecule has an Fc region that binds to at least one activating Fcγ receptor. The binding of this second antibody to the immune cell receptor leads to the depletion and/or deactivation of the immune cell, providing a novel approach to treating FcγRIIb-negative cancers in patients. Additionally, he has developed a patent related to medicaments, uses, and methods for treating refractory and relapsed cancers, which includes compositions comprising an antibody molecule and an agent.

Career Highlights

Throughout his career, Ali Roghanian has worked with esteemed institutions such as the University of Southampton and Bioinvent International AB. His research has focused on advancing the understanding of antibody interactions and their therapeutic potential in oncology.

Collaborations

Roghanian has collaborated with notable professionals in the field, including Mark Steven Cragg and Ingrid Teige. These collaborations have contributed to the advancement of his research and the development of innovative cancer therapies.

Conclusion

Ali Roghanian's contributions to the field of cancer treatment through his innovative patents highlight his commitment to improving patient care. His work continues to pave the way for new therapeutic strategies in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…